Innovative UNC-based Public-Private HIV Investigative Group Secures $20m & Continues its Leading ‘Induce & Reduce’ Strategy

Innovative UNC-based Public-Private HIV Investigative Group Secures $20m & Continues its Leading ‘Induce & Reduce’ Strategy

University of North Carolina (UNC) Chapel Hill researchers and local industry scientists secured $20 million in the from of a research contract targeting a cure for HIV. The deal was executed between ViiV Healthcare and UNC at Chapel Hill to renew the unique,...
Australian Investigators Find Antibody to Neutralize Henipaviruses Safe & Well Tolerated in Healthy Volunteers in Phase I Clinical Trial

Australian Investigators Find Antibody to Neutralize Henipaviruses Safe & Well Tolerated in Healthy Volunteers in Phase I Clinical Trial

The first ever treatment for preventing a group of viruses from causing potentially deadly infections has been successfully tested in a Phase I clinical trial. The monoclonal antibody, m102.4 was found to be safe and able to neutralize the viruses based on the results...
University Hospitals Seidman Cancer Center Treats its First Glioblastoma Patient with Duke-Originated Genetically Modified Polio Virus

University Hospitals Seidman Cancer Center Treats its First Glioblastoma Patient with Duke-Originated Genetically Modified Polio Virus

University Hospitals Seidman Cancer Center (UH) treated its first patient in a new clinical trial to validate groundbreaking effects of poliovirus on glioblastoma (GBM), a deadly Grade IV cancer of the brain. UH was the only Midwest site that participated in this...

Pin It on Pinterest